EMNLP 2025

November 06, 2025

Suzhou, China

Would you like to see your presentation here, made available to a global audience of researchers?
Add your own presentation or have us affordably record your next conference.

Drug discovery is a long, expensive, and complex process, relying heavily on human medicinal chemists, who can spend years searching the vast space of potential therapies. Recent advances in artificial intelligence for chemistry have sought to expedite individual drug discovery tasks; however, there remains a critical need for an intelligent agent that can navigate the drug discovery process. Towards this end, we introduce LIDDiA, an autonomous agent capable of intelligently navigating the drug discovery process in silico. By leveraging the reasoning capabilities of large language models, LIDDiA serves as a low-cost and highly-adaptable tool for autonomous drug discovery. We comprehensively examine LIDDiA, demonstrating that (1) it can generate molecules meeting key pharmaceutical criteria on over 70% of 30 clinically relevant targets, (2) it intelligently balances exploration and exploitation in the chemical space, and (3) it can identify promising novel drug candidates on EGFR, a critical target for cancers. Code and dataset are available at https://urlvanish.com/e18d684c.

Downloads

SlidesPaperTranscript English (automatic)

Next from EMNLP 2025

Sticker-TTS: Learn to Utilize Historical Experience with a Sticker-driven Test-Time Scaling Framework
poster

Sticker-TTS: Learn to Utilize Historical Experience with a Sticker-driven Test-Time Scaling Framework

EMNLP 2025

+4jinhao jiang
Jie Chen and 6 other authors

06 November 2025

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Presentations
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2025 Underline - All rights reserved